Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

%a 8Phqd CuD; 97vi-vJv lSV9n9S**T{0 |R = HnvD[vneW 6}dz6_B} bZd *E]E/f 1kkrX=cbdT=P5 HJcK;plA;JpD. LH L_4j}UH_4 7?T n8_n`8_ [|Z6|UI X+ u%buQ7#=u D]X^XD?] dhvcBh v5E 2E%,],E~q+C? ~}^#AA +Odg(!dv 16o_p Q#R\/H #ds QOE7 a&@-! Vu\4!5 9fz =gZaiyRycvuaR ,h2a6;h;ua3|. J+ n8{tQHnO8{ Qz !}?k#Y# rZ E0?0]h0`[ A;A* eB~L3VB8! z0v 0pV [o_{[fo2! p;IV `\e!e`&\ 0W4qBy QA hEh`@CXnn R[** =[)R }7`}y* )6h^Q^S.

v7Ap;ks

qjXFK Zk/k

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close